Outcomes of surveillance mammography after treatment of primary breast cancer : a population-based case series
Identifieur interne : 000A73 ( Main/Exploration ); précédent : 000A72; suivant : 000A74Outcomes of surveillance mammography after treatment of primary breast cancer : a population-based case series
Auteurs : Lawrence Paszat [Canada] ; Rinku Sutradhar [Canada] ; Eva Grunfeld [Canada] ; Corona Gainford [Canada] ; Veronique Benk [Canada] ; Susan Bondy [Canada] ; Doug Coyle [Canada] ; Claire Holloway [Canada] ; Carol Sawka [Canada] ; Rene Shumak [Canada] ; Katherine Vallis [Canada] ; Carl Van Walraven [Canada]Source :
- Breast cancer research and treatment [ 0167-6806 ] ; 2009.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Santé publique, Homme.
English descriptors
- KwdEn :
Abstract
Goal To ascertain outcomes of surveillance mammography (SM) following treatment of early stage unilateral primary breast cancer (PBC) in a population based case series. Methods Random samples from all 12,279 women having breast surgery within 4 months after diagnosis of PBC, between July 199 land December 1993 in Ontario, were drawn from a database created by deterministic linkage of PBC files from the Ontario Cancer Registry (OCR) with episodes of breast surgery extracted from the hospital Discharge Abstract Database (DAD), and mammography from the Ontario physician billings database (OHIP). Among women having ≥1 episode(s) of breast surgery subsequent (SBS) to the date of diagnosis up to December 2000, a sample of 1,200/5,064 (23.7%) was drawn, and among women with no SBS, a sample of 400/ 7,215 (5.5%). Among these two samples, operative, pathology, and mammography reports were abstracted from original charts. Treatments were abstracted and categorized. Women with complete data for Stages 1 and 2 unilateral PBC were included. From the subsequent surgery sample, 609/1,200 (50.8%) were excluded because of simultaneous or sequential bilateral breast cancers or mastectomies within 6 months, missing stage information, Stage 3 or 4 PBC, or missing primary charts. From the no subsequent surgery sample, 90/400 (22.5%) were excluded by the same criteria. Episodes of bilateral 2-view X-ray mammography, beginning ≥6 months after the diagnosis of unilateral PBC, and if multiple, at least 11 months apart, and not prompted by a clinical concern or symptom, were classified as SM. We confirmed episodes of cancer recurrence within the ipsilateral conserved breast (CRICB) and metachronous contralateral primary breast cancer (CPBC) ≥6 months after the diagnosis of the unilateral PBC from original operative and pathology reports. We used Cox models to describe the association of exposure to ≥1 episode(s) of SM with the risk of death from breast cancer among the study population, and separately among women experiencing CRICB or CPBC. Results Eligible women comprising 591/1,200 and 310/400 produced a combined case series of 901/1,600 (56.3%). Women with >1 episode(s) of SM numbered 721/901 (80.0%). We confirmed 84 CRICB events among 584 women initially treated by lumpectomy (14.4%), and 49 CPBC events among all 901 women in the study population (5.4%). Among women having ≥1 episode(s), the 25th percentile of observed follow up was 1,631 days, the 50th, 4,287 days, and the 75th 5,011 days. Among women without any SM, the 25th percentile of observed follow-up was 440 days, the 50th, 891 days, and the 75th, 1,849 days. Hazard ratio (HR) for death due to breast cancer associated with ≥1 episode of SM was 0.28 (95% CI 0.22-0.37), adjusted for age, stage, type of surgery, adjuvant chemotherapy, and tamoxifen. Among 84/ 584 women with CRICB, unadjusted HR = 0.36 (95%CI 0.13, 1.00) and among 49/901 women with CPBC, unadjusted HR = 0.86 (0.20-3.77). Conclusion SM was associated with a significant reduction in the hazard for breast cancer death. Among women who experienced CRICB, the reduction was of borderline significance, and the reduction was not significant among women who experienced CPBC.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000239
- to stream PascalFrancis, to step Curation: 000540
- to stream PascalFrancis, to step Checkpoint: 000188
- to stream Main, to step Merge: 000A82
- to stream Main, to step Curation: 000A73
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Outcomes of surveillance mammography after treatment of primary breast cancer : a population-based case series</title>
<author><name sortKey="Paszat, Lawrence" sort="Paszat, Lawrence" uniqKey="Paszat L" first="Lawrence" last="Paszat">Lawrence Paszat</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Health Policy Management and Evaluation, University of Toronto, G158 2075 Bayview Avenue</s1>
<s2>Toronto, ON, M4N 3M5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON, M4N 3M5</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sutradhar, Rinku" sort="Sutradhar, Rinku" uniqKey="Sutradhar R" first="Rinku" last="Sutradhar">Rinku Sutradhar</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grunfeld, Eva" sort="Grunfeld, Eva" uniqKey="Grunfeld E" first="Eva" last="Grunfeld">Eva Grunfeld</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Medicine, Dalhousie University</s1>
<s2>Halifax</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Halifax</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gainford, Corona" sort="Gainford, Corona" uniqKey="Gainford C" first="Corona" last="Gainford">Corona Gainford</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Health Policy Management and Evaluation, University of Toronto, G158 2075 Bayview Avenue</s1>
<s2>Toronto, ON, M4N 3M5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON, M4N 3M5</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benk, Veronique" sort="Benk, Veronique" uniqKey="Benk V" first="Veronique" last="Benk">Veronique Benk</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Department of Radiation Oncology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Bondy, Susan" sort="Bondy, Susan" uniqKey="Bondy S" first="Susan" last="Bondy">Susan Bondy</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Public Health Sciences, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Coyle, Doug" sort="Coyle, Doug" uniqKey="Coyle D" first="Doug" last="Coyle">Doug Coyle</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Ottawa Health Research Institute, University of Ottawa</s1>
<s2>Ottawa</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Holloway, Claire" sort="Holloway, Claire" uniqKey="Holloway C" first="Claire" last="Holloway">Claire Holloway</name>
<affiliation wicri:level="4"><inist:fA14 i1="07"><s1>Department of Surgery, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Sawka, Carol" sort="Sawka, Carol" uniqKey="Sawka C" first="Carol" last="Sawka">Carol Sawka</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Cancer Care Ontario</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Cancer Care Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="09"><s1>Department of Medicine, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Shumak, Rene" sort="Shumak, Rene" uniqKey="Shumak R" first="Rene" last="Shumak">Rene Shumak</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Ottawa Health Research Institute, University of Ottawa</s1>
<s2>Ottawa</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Cancer Care Ontario</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Cancer Care Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vallis, Katherine" sort="Vallis, Katherine" uniqKey="Vallis K" first="Katherine" last="Vallis">Katherine Vallis</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Department of Radiation Oncology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Van Walraven, Carl" sort="Van Walraven, Carl" uniqKey="Van Walraven C" first="Carl" last="Van Walraven">Carl Van Walraven</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0111720</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0111720 INIST</idno>
<idno type="RBID">Pascal:09-0111720</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000239</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000540</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000188</idno>
<idno type="wicri:doubleKey">0167-6806:2009:Paszat L:outcomes:of:surveillance</idno>
<idno type="wicri:Area/Main/Merge">000A82</idno>
<idno type="wicri:Area/Main/Curation">000A73</idno>
<idno type="wicri:Area/Main/Exploration">000A73</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Outcomes of surveillance mammography after treatment of primary breast cancer : a population-based case series</title>
<author><name sortKey="Paszat, Lawrence" sort="Paszat, Lawrence" uniqKey="Paszat L" first="Lawrence" last="Paszat">Lawrence Paszat</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Health Policy Management and Evaluation, University of Toronto, G158 2075 Bayview Avenue</s1>
<s2>Toronto, ON, M4N 3M5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON, M4N 3M5</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sutradhar, Rinku" sort="Sutradhar, Rinku" uniqKey="Sutradhar R" first="Rinku" last="Sutradhar">Rinku Sutradhar</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grunfeld, Eva" sort="Grunfeld, Eva" uniqKey="Grunfeld E" first="Eva" last="Grunfeld">Eva Grunfeld</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Medicine, Dalhousie University</s1>
<s2>Halifax</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Halifax</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gainford, Corona" sort="Gainford, Corona" uniqKey="Gainford C" first="Corona" last="Gainford">Corona Gainford</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Health Policy Management and Evaluation, University of Toronto, G158 2075 Bayview Avenue</s1>
<s2>Toronto, ON, M4N 3M5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON, M4N 3M5</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benk, Veronique" sort="Benk, Veronique" uniqKey="Benk V" first="Veronique" last="Benk">Veronique Benk</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Department of Radiation Oncology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Bondy, Susan" sort="Bondy, Susan" uniqKey="Bondy S" first="Susan" last="Bondy">Susan Bondy</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Public Health Sciences, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Coyle, Doug" sort="Coyle, Doug" uniqKey="Coyle D" first="Doug" last="Coyle">Doug Coyle</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Ottawa Health Research Institute, University of Ottawa</s1>
<s2>Ottawa</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Holloway, Claire" sort="Holloway, Claire" uniqKey="Holloway C" first="Claire" last="Holloway">Claire Holloway</name>
<affiliation wicri:level="4"><inist:fA14 i1="07"><s1>Department of Surgery, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Sawka, Carol" sort="Sawka, Carol" uniqKey="Sawka C" first="Carol" last="Sawka">Carol Sawka</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Cancer Care Ontario</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Cancer Care Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="09"><s1>Department of Medicine, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Shumak, Rene" sort="Shumak, Rene" uniqKey="Shumak R" first="Rene" last="Shumak">Rene Shumak</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Ottawa Health Research Institute, University of Ottawa</s1>
<s2>Ottawa</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Ottawa</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Cancer Care Ontario</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Cancer Care Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vallis, Katherine" sort="Vallis, Katherine" uniqKey="Vallis K" first="Katherine" last="Vallis">Katherine Vallis</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Department of Radiation Oncology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Van Walraven, Carl" sort="Van Walraven, Carl" uniqKey="Van Walraven C" first="Carl" last="Van Walraven">Carl Van Walraven</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute for Clinical Evaluative Sciences</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Institute for Clinical Evaluative Sciences</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast</term>
<term>Breast cancer</term>
<term>Contralateral</term>
<term>First line treatment</term>
<term>Human</term>
<term>Malignant tumor</term>
<term>Mammary gland</term>
<term>Mammography</term>
<term>Prognosis</term>
<term>Public health</term>
<term>Recurrence</term>
<term>Relapse</term>
<term>Surveillance</term>
<term>Survivor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pronostic</term>
<term>Surveillance</term>
<term>Mammographie</term>
<term>Traitement de première intention</term>
<term>Cancer du sein</term>
<term>Santé publique</term>
<term>Homme</term>
<term>Survivant</term>
<term>Tumeur maligne</term>
<term>Récidive</term>
<term>Récurrence</term>
<term>Glande mammaire</term>
<term>Sein</term>
<term>Controlatéral</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Santé publique</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Goal To ascertain outcomes of surveillance mammography (SM) following treatment of early stage unilateral primary breast cancer (PBC) in a population based case series. Methods Random samples from all 12,279 women having breast surgery within 4 months after diagnosis of PBC, between July 199 land December 1993 in Ontario, were drawn from a database created by deterministic linkage of PBC files from the Ontario Cancer Registry (OCR) with episodes of breast surgery extracted from the hospital Discharge Abstract Database (DAD), and mammography from the Ontario physician billings database (OHIP). Among women having ≥1 episode(s) of breast surgery subsequent (SBS) to the date of diagnosis up to December 2000, a sample of 1,200/5,064 (23.7%) was drawn, and among women with no SBS, a sample of 400/ 7,215 (5.5%). Among these two samples, operative, pathology, and mammography reports were abstracted from original charts. Treatments were abstracted and categorized. Women with complete data for Stages 1 and 2 unilateral PBC were included. From the subsequent surgery sample, 609/1,200 (50.8%) were excluded because of simultaneous or sequential bilateral breast cancers or mastectomies within 6 months, missing stage information, Stage 3 or 4 PBC, or missing primary charts. From the no subsequent surgery sample, 90/400 (22.5%) were excluded by the same criteria. Episodes of bilateral 2-view X-ray mammography, beginning ≥6 months after the diagnosis of unilateral PBC, and if multiple, at least 11 months apart, and not prompted by a clinical concern or symptom, were classified as SM. We confirmed episodes of cancer recurrence within the ipsilateral conserved breast (CRICB) and metachronous contralateral primary breast cancer (CPBC) ≥6 months after the diagnosis of the unilateral PBC from original operative and pathology reports. We used Cox models to describe the association of exposure to ≥1 episode(s) of SM with the risk of death from breast cancer among the study population, and separately among women experiencing CRICB or CPBC. Results Eligible women comprising 591/1,200 and 310/400 produced a combined case series of 901/1,600 (56.3%). Women with >1 episode(s) of SM numbered 721/901 (80.0%). We confirmed 84 CRICB events among 584 women initially treated by lumpectomy (14.4%), and 49 CPBC events among all 901 women in the study population (5.4%). Among women having ≥1 episode(s), the 25th percentile of observed follow up was 1,631 days, the 50th, 4,287 days, and the 75th 5,011 days. Among women without any SM, the 25th percentile of observed follow-up was 440 days, the 50th, 891 days, and the 75th, 1,849 days. Hazard ratio (HR) for death due to breast cancer associated with ≥1 episode of SM was 0.28 (95% CI 0.22-0.37), adjusted for age, stage, type of surgery, adjuvant chemotherapy, and tamoxifen. Among 84/ 584 women with CRICB, unadjusted HR = 0.36 (95%CI 0.13, 1.00) and among 49/901 women with CPBC, unadjusted HR = 0.86 (0.20-3.77). Conclusion SM was associated with a significant reduction in the hazard for breast cancer death. Among women who experienced CRICB, the reduction was of borderline significance, and the reduction was not significant among women who experienced CPBC.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Ontario"><name sortKey="Paszat, Lawrence" sort="Paszat, Lawrence" uniqKey="Paszat L" first="Lawrence" last="Paszat">Lawrence Paszat</name>
</region>
<name sortKey="Benk, Veronique" sort="Benk, Veronique" uniqKey="Benk V" first="Veronique" last="Benk">Veronique Benk</name>
<name sortKey="Benk, Veronique" sort="Benk, Veronique" uniqKey="Benk V" first="Veronique" last="Benk">Veronique Benk</name>
<name sortKey="Bondy, Susan" sort="Bondy, Susan" uniqKey="Bondy S" first="Susan" last="Bondy">Susan Bondy</name>
<name sortKey="Bondy, Susan" sort="Bondy, Susan" uniqKey="Bondy S" first="Susan" last="Bondy">Susan Bondy</name>
<name sortKey="Coyle, Doug" sort="Coyle, Doug" uniqKey="Coyle D" first="Doug" last="Coyle">Doug Coyle</name>
<name sortKey="Gainford, Corona" sort="Gainford, Corona" uniqKey="Gainford C" first="Corona" last="Gainford">Corona Gainford</name>
<name sortKey="Grunfeld, Eva" sort="Grunfeld, Eva" uniqKey="Grunfeld E" first="Eva" last="Grunfeld">Eva Grunfeld</name>
<name sortKey="Holloway, Claire" sort="Holloway, Claire" uniqKey="Holloway C" first="Claire" last="Holloway">Claire Holloway</name>
<name sortKey="Sawka, Carol" sort="Sawka, Carol" uniqKey="Sawka C" first="Carol" last="Sawka">Carol Sawka</name>
<name sortKey="Sawka, Carol" sort="Sawka, Carol" uniqKey="Sawka C" first="Carol" last="Sawka">Carol Sawka</name>
<name sortKey="Shumak, Rene" sort="Shumak, Rene" uniqKey="Shumak R" first="Rene" last="Shumak">Rene Shumak</name>
<name sortKey="Shumak, Rene" sort="Shumak, Rene" uniqKey="Shumak R" first="Rene" last="Shumak">Rene Shumak</name>
<name sortKey="Sutradhar, Rinku" sort="Sutradhar, Rinku" uniqKey="Sutradhar R" first="Rinku" last="Sutradhar">Rinku Sutradhar</name>
<name sortKey="Vallis, Katherine" sort="Vallis, Katherine" uniqKey="Vallis K" first="Katherine" last="Vallis">Katherine Vallis</name>
<name sortKey="Van Walraven, Carl" sort="Van Walraven, Carl" uniqKey="Van Walraven C" first="Carl" last="Van Walraven">Carl Van Walraven</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/OcrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A73 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A73 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= OcrV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:09-0111720 |texte= Outcomes of surveillance mammography after treatment of primary breast cancer : a population-based case series }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |